This module uses fundamental data of Alterola Biotech to approximate its Piotroski F score. Alterola Biotech F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Alterola Biotech. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Alterola Biotech financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out
Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
At this time, it appears that Alterola Biotech's Piotroski F Score is Inapplicable. Although some professional money managers and academia have recently criticized
Piotroski F-Score model, we still consider it an effective method of
predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
0.0
Piotroski F Score - Inapplicable
| Current Return On Assets | N/A | Focus |
| Change in Return on Assets | N/A | Focus |
| Cash Flow Return on Assets | N/A | Focus |
| Current Quality of Earnings (accrual) | N/A | Focus |
| Asset Turnover Growth | N/A | Focus |
| Current Ratio Change | N/A | Focus |
| Long Term Debt Over Assets Change | N/A | Focus |
| Change In Outstending Shares | N/A | Focus |
| Change in Gross Margin | N/A | Focus |
Alterola Biotech Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Alterola Biotech is to make sure Alterola is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Alterola Biotech's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Alterola Biotech's financial numbers are properly reported.
About Alterola Biotech Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled
Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
Currently Active Assets on Macroaxis
Other Information on Investing in Alterola Pink Sheet
Alterola Biotech financial ratios help investors to determine whether Alterola Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alterola with respect to the benefits of owning Alterola Biotech security.